«Factor Viia

Below is an extended Factor Viia news listing. Click here to return to the Factor Viia main in depth entry.

BioNews Results for Factor Viia:
Stop the bleeding Drug Discovery News:  Aug 27 2008 6:58AM Matching: factor viia
Rx Product News: Profile: A Closer Look at New FDA Actions: NovoSeven RT Pharmacy Times:  Aug 22 2008 4:26AM Matching: factor viia
Neose Technologies to Appeal NASDAQ Global Market Delisting Notification SmartBrief:  Aug 22 2008 11:05AM Matching: factor viia
Neose Technologies to Appeal NASDAQ Global Market Delisting Notification Pharma Live:  Aug 21 2008 1:43PM Matching: factor viia
Neose Technologies to Appeal NASDAQ Global Market Delisting Notification Genetic Engineering News:  Aug 21 2008 1:25PM Matching: factor viia
GTC Biotherapeutics and OVATION Pharmaceuticals Close Agreement to Market and Develop ATryn(R) in the U.S DiGiTAL50:  Aug 16 2008 12:48AM Matching: factor viia
Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results KRON4:  Aug 14 2008 3:21PM Matching: factor viia
Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results KLFY:  Aug 14 2008 12:43PM Matching: factor viia
Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results KOTA Territory News:  Aug 14 2008 11:58AM Matching: factor viia
Breast Cancer Therapy - Researchers from Temple University, Research Center report recent findings in breast c NewsRX:  Aug 14 2008 1:56PM Matching: factor viia
::: CSL Full Year Result Biotech Intelligence:  Aug 14 2008 4:46AM Matching: factor viia
Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results Pharma Live:  Aug 14 2008 12:12PM Matching: factor viia
GTC Biotherapeutics and OVATION Pharmaceuticals Close Agreement to Market and Develop ATryn(R) in the U.S Genetic Engineering News:  Aug 14 2008 3:41PM Matching: factor viia
GTC Biotherapeutics and Ovation Pharmaceuticals Close Agreement to Market and Develop ATryn in the U.S Pharma Live:  Aug 14 2008 1:08PM Matching: factor viia
GTC Biotherapeutics and OVATION Pharmaceuticals Close Agreement to Market and Develop ATryn(R) in the U.S Houston Chronicle:  Aug 14 2008 12:45PM Matching: factor viia

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.